drugset / Trial / NCT00407446

PDE5-Inhibition With Sildenafil in Chronic Heart Failure

NCT00407446

Phase 3 Completed 40 enrolled University of Milan
RandomizedParallel-groupDouble-blindTreatment

Summary

To test the hypothesis that long-term PDE5-inhibition by overexpressing the nitric oxide pathway is beneficial in chronic heart failure patients. Double-blind and placebo-controlled trial. Primary end-points: quality of life and exercise performance

Timeline

Start
2004-01
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown

Indications